Annual report
9158.TEDINET S100R9VL
Period2022-04-01 → 2023-03-31
Filed2023-06-29
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Amended by S100S3W6 (2023-11-01).
Key figures · 117
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥35.2bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥35.3bn | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥16.6bn | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥3.7bn | 2022-04-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥3.7bn | 2021-04-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥3.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥3.6bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥1.6bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥2.7bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥1.1bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥2.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥39.8bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥34.5bn | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥28.4bn | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥27.8bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥24.8bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥11.9bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥9.7bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥5.3bn | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥11.7bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥9.5bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥4.7bn | at 2021-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥4.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥4.4bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥3.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥6.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥2.1bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥6.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥1.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥2.4bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | ¥4.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥4.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥591m | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥113.9 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥129.68 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥52.71 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥113.9 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥129.68 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥52.71 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥533.1 | at 2023-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥453.12 | at 2022-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥226.83 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 29.4% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 27.4% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 16.6% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 22.9% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 38.1% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 27.1% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 2,994 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 2,470 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 1,819 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥14.3bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥15.4bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥4.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.9bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥2.5bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.8bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.4bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥795m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥312m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥779m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.8bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.4bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.3bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥1.7bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥574m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥122m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥511m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥28.4bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥23.9bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥19.4bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.6bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥11.5bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥20.3bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥16.5bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥8.1bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.4bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.9bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥3.3bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.2bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥554m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥260m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥60.21 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.53 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.98 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,145.5 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4,861.53 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥365.69 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥335.57 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥176.49 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥30,101.95 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥11,336.83 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 28.4% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.9% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 20.1% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.9% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 10.4% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.6% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 30.6% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.9% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 54.6% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 113,152 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 104,352 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 104,352 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 104,352 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 100,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 423 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 374 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 304 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 310 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 263 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-03-31 | 5 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥205m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥205m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥29m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥263m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥263m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥843m |
| In Home Nursing Hospicereportable segment | employees | at 2023-03-31 | 2352 pure |
| In Home Nursing Hospicereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥18.8bn |
| In Home Nursing Hospicereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥18.8bn |
| In Home Nursing Hospicereportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.5bn |
| Management Supportreportable segment | employees | at 2023-03-31 | 560 pure |
| Management Supportreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥16.4bn |
| Management Supportreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥16.2bn |
| Management Supportreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥263m |
| Management Supportreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥3.0bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥35.3bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥35.0bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥263m |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥35.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥35.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥263m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥4.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥764m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥764m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥159m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥202m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥202m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥609m |
| In Home Nursing Hospicereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥17.4bn |
| In Home Nursing Hospicereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥17.4bn |
| In Home Nursing Hospicereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥2.7bn |
| Management Supportreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥17.4bn |
| Management Supportreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥17.2bn |
| Management Supportreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥202m |
| Management Supportreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.4bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥34.8bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥34.6bn |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥202m |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥4.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥35.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥35.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥202m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥4.3bn |
| Management Supportreportable segment | employees | at 2023-03-31 | 346 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,542
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 2266000 | |
| Audit fees reporting company | Prior1YearDuration | 58000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | 9000000 | JPY |
| Audit fees reporting company | CurrentYearDuration | 79000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 58000000 | JPY |
| Non audit fees total | Prior1YearDuration | 9000000 | JPY |
| Audit fees total | CurrentYearDuration | 79000000 | JPY |
| Non audit fees total | CurrentYearDuration | － | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000DirectorsExcludingAuditAndSupervisoryCommitteeMembersMember | 73000000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000DirectorsExcludingAuditAndSupervisoryCommitteeMembersMember | 73000000 | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000DirectorsExcludingAuditAndSupervisoryCommitteeMembersMember | － | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000DirectorsExcludingAuditAndSupervisoryCommitteeMembersMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000DirectorsExcludingAuditAndSupervisoryCommitteeMembersMember | 4 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000OfWhichOutsideDirectorsMember | 0 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000OfWhichOutsideDirectorsMember | 0 | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000OfWhichOutsideDirectorsMember | － | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000OfWhichOutsideDirectorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000OfWhichOutsideDirectorsMember | 1 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000DirectorsAuditAndSupervisoryCommitteeMembersMember | 11000000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000DirectorsAuditAndSupervisoryCommitteeMembersMember | 11000000 | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000DirectorsAuditAndSupervisoryCommitteeMembersMember | － | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000DirectorsAuditAndSupervisoryCommitteeMembersMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000DirectorsAuditAndSupervisoryCommitteeMembersMember | 2 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000OutsideDirectorsOfAuditAndSupervisoryCommitteeMembersMember | 11000000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000OutsideDirectorsOfAuditAndSupervisoryCommitteeMembersMember | 11000000 | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000OutsideDirectorsOfAuditAndSupervisoryCommitteeMembersMember | － | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000OutsideDirectorsOfAuditAndSupervisoryCommitteeMembersMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37214-000OutsideDirectorsOfAuditAndSupervisoryCommitteeMembersMember | 2 | |
| Number of issues shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | － | |
| Carrying amount shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | － | JPY |
| Number of issues shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 1 | |
| Carrying amount shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 2038000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | 840000 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row1Member | 420000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | 2038000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row1Member | 2885000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 4355000000 | JPY |
| Cash and cash equivalents IFRS | CurrentYearInstant | 4120000000 | JPY |
| Trade and other receivables ca IFRS | Prior1YearInstant | 10515000000 | JPY |
| Trade and other receivables ca IFRS | CurrentYearInstant | 8240000000 | JPY |
| Inventories ca IFRS | Prior1YearInstant | 47000000 | JPY |
| Inventories ca IFRS | CurrentYearInstant | 44000000 | JPY |
| Other financial assets ca IFRS | Prior1YearInstant | 22000000 | JPY |
| Other financial assets ca IFRS | CurrentYearInstant | 77000000 | JPY |
| Other current assets ca IFRS | Prior1YearInstant | 214000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |